Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival.
Daniel Antunes MorenoLuciane Sussuchi da SilvaIsabella GomesLetícia Ferro LealGustavo Noriz BerardinelliGisele Melo GonçalvesCaio Augusto PereiraIara Viana Vidigal SantanaMarcus de Medeiros MatsushitaKrishna BhatSean LawlerRui Manuel Vieira ReisPublished in: Therapeutic advances in medical oncology (2022)
GBM patients. Increased immune functions, CD45, cytotoxic cells, and macrophage scores were associated with a more aggressive phenotype and may provide promising possibilities for therapy. Moreover, a 12 gene-based signature could predict patients' prognosis.